262例肺结核患者耐药情况分析及治疗探讨

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:guanyucomputer
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的探讨262例肺结核患者痰培养阳性菌株对十种抗结核药物的耐药性。并对耐INH、RFP、SM及HR者等进行了敏感药物的选择。方法全部痰培养阳性标本由实验室作药敏测定,并对敏感药物进行治疗效果观察。结果 262株分支杆菌耐单药顺位次序为:RFP40.8%、SM36.6%、INH38.9%、1321TH20.8%、EMB10.7%、PAS7.6%、KM6.9%、DiP5.7%、CPM4.3%、OFLX4.3%。对耐HR64例患者治疗中应用DiP、OFLX、CPM方案,6个月痰菌阴转率达79.7%。结论我市属于高耐药区域,以耐RFP、SM、INH者居前三位。DiP、OFLX、CPM对耐HR者有疗效。 Objective To investigate the resistance of sputum culture positive strains to ten kinds of anti-tuberculosis drugs in 262 pulmonary tuberculosis patients. And resistant to INH, RFP, SM and HR who were sensitive to drug selection. Methods All sputum culture positive samples were determined by the laboratory for drug susceptibility, and the treatment of sensitive drugs was observed. Results The order of single drug resistance to Mycobacterium tuberculosis was RFP40.8%, SM36.6%, INH38.9%, 1321TH20.8%, EMB10.7%, PAS7.6%, KM6.9%, DiP5. 7%, CPM4.3%, OFLX4.3%. DiP, OFLX, and CPM regimens were used in the treatment of HR64-resistant patients and the sputum negative conversion rate was 79.7% at 6 months. Conclusion The city belongs to the high resistance area, with the resistance of RFP, SM, INH among the top three. DiP, OFLX, CPM is effective against HR.
其他文献
中煤龙化公司是中煤集团公司的控股二级子公司,是一家大型的煤炭开采和煤化工综合生产企业。根据企业生产经营及能耗、排污特点,被集团公司列为第一类(重点企业)。公司自2007
期刊
期刊
期刊
期刊
期刊
洼38块东二段油层属三角洲前缘亚相沉积,储层以薄互层中、细砂岩为主,单层厚度小,不足5m,且横向变化快。2008年,该块开展了以水平井为主导技术的二次开发试验,应用传统LWD导
选用甲壳素纤维与棉混纺的纱线,编织成薄型甲壳素纤维多功能袜,解决了消费者特别是男士对夏季袜品选择出现的困惑.该款薄型甲壳素纤维多功能袜对人体有良好的保健作用,具有抑
期刊